Per Lundin
Director/Board Member at COMBIGENE AB
Per Lundin active positions
Companies | Position | Start | End |
---|---|---|---|
COMBIGENE AB | Director/Board Member | 2019-12-31 | - |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 2018-12-19 | - |
Chief Executive Officer | 2024-04-28 | - | |
Founder | 2015-12-31 | - | |
Chief Operating Officer | 2015-12-31 | - | |
Corporate Officer/Principal | - | 2024-04-28 | |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Director/Board Member | - | - |
Career history of Per Lundin
Former positions of Per Lundin
Companies | Position | Start | End |
---|---|---|---|
IsletOne Therapeutics | Director/Board Member | 2012-11-30 | 2019-08-31 |
Chief Executive Officer | 2012-11-30 | 2016-03-31 | |
Founder | 2012-11-30 | 2016-03-31 | |
Thomson Reuters Holdings AB | Corporate Officer/Principal | 2011-10-31 | 2016-03-31 |
Training of Per Lundin
Karolinska Institutet | Doctorate Degree |
Stockholm Business School | Masters Business Admin |
Royal Institute of Technology | Graduate Degree |
Statistics
International
Sweden | 7 |
United Kingdom | 2 |
United States | 2 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
COMBIGENE AB | Health Technology |
Private companies | 4 |
---|---|
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Health Technology |
IsletOne Therapeutics | |
Thomson Reuters Holdings AB | |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Per Lundin
- Experience